Cepsa has successfully carried out the first trial in Spain of advanced biofuels (2G) in one of the ships used by the company, the Montestena, owned by Ibaizabal, during several weeks of navigation.
The dual ROV vessel is expected to be available to clients early in the second quarter of 2023 following a conversion of the SW Tasman multipurpose vessel.